Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-20

Clinical Trial Update: Mechanisms of N-acetylcysteine Mediated Vascular Adverse Effects [NA]

View source ↗

Summary

Clinical trial update indicates the study on mechanisms of N-acetylcysteine–mediated vascular adverse effects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: University of Edinburgh | Conditions: Poisoning | NA | Status: COMPLETED